hookipapharma.com (HOOK) Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization
The daily price action for HOOKIPA Pharma Inc. (HOOK) illustrated below demonstrates the metric, while the business relies on the development of anti-tumor vaccines, depending on test results and external contracts. HOOKIPA Pharma Inc. (HOOK) is implementing automated systems for big data analysis and robotic molecule screening. The firm's highest potential is based on the development of unique cancer immunotherapy methods using T-cell programming.
hookipapharma.com - analytical breakdowns and key metrics (HOOK)
- current price and projected stock value:
- market capitalization details:
- book value of equity indicators:
- debt level and financial liquidity data:
Debt to Equity HOOKIPA Pharma Inc.|HOOK - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital HOOKIPA Pharma|HOOK - Company Cumulative Debt|Debts to Book Capitalization HOOKIPA Pharma Inc.|HOOK - Company Long-Term Loans and Borrowings|Company Short-Term Debt HOOKIPA Pharma|Quick Liquidity hookipapharma.com
- business earnings and investment ratios data:
HOOK - Company Net Income|Expected Profit HOOKIPA Pharma Inc.|HOOK - P/E Multiple|Forward P/E Multiple HOOKIPA Pharma|HOOK - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization HOOKIPA Pharma Inc.|HOOK - Profit before deduction of interest, taxes, depreciation and amortization|Net earnings per share (EPS TTM) HOOKIPA Pharma|HOOK - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months hookipapharma.com|HOOK - Earnings per share increase in current year|Net earnings per share growth forecast for next year HOOKIPA Pharma Inc.
Initial company analysis:HOOKIPA HOOK
An investment audit of the issuer requires a thorough analysis of business value relative to its ability to generate cash flow. The EV/EBITDA ratio correlates the total value of the company (market capitalization plus net debt) with earnings before depreciation, taxes, and interest, determining the payback period of the assets. For HOOKIPA Pharma Inc. (HOOK) and its immunotherapy developments, the EV/EBITDA trend reflects the market's valuation of the platform's potential against research expenditures.
Key competitors
EV/EBITDA Multiple ARGX (Argenx)|Total Company Value to Operating Income Before Depreciation Ratio BioNTech Pharma (BNTX)|ABVX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|admabiologics.com (ADMA) - Enterprise Value to EBITDA Ratio|Protagonist (PTGX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Immunovant Inc|Enterprise Value to EBITDA Ratio KNSA|EV/EBITDA Multiple Grifols Biemat|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Adaptive Biotechnologies (ADPT)|celldex.com - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple AUPH (Aurinia Pharmaceuticals Inc.)|BioCryst Pharmaceuticals, Inc. (BCRX) - Company Value to EBITDA|Vera Pharma - EV/EBITDA Multiple|Business Value to Operating Income Before Depreciation DNTH (Dianthus Corp)|Pharvaris N.V. (PHVS) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to EBITDA AbCellera (ABCL)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Tourmaline Bio|Company Value to EBITDA Precigen Inc PGEN|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Pharming (PHAR)|EV/EBITDA Multiple Nektar Corp (NKTR)|EV/EBITDA Multiple UPB (Upstream Bio Inc)|Total Company Value to Operating Income Before Depreciation Ratio zenasbio.com (ZBIO)|IMNM - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio GOSS|KALV: EV/EBITDA Multiple|Septerna Pharma (SEPN) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio PVLA|SVRA: Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Rigel Pharmaceuticals, Inc. (RIGL)|ANAB: Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple ATXS (Astria Pharma)|Business Value to Operating Income Before Depreciation ENGN|RAPT Therapeutics - EV/EBITDA Multiple|JBIO - EV/EBITDA Multiple|Aclaris Therapeutics, Inc. (ACRS) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Kyverna Therapeutics Inc. - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Tiziana Life Sciences PLC|Enterprise Value to EBITDA Ratio Cabaletta Bio Inc (CABA)|EV/EBITDA Multiple VTYX|EV/EBITDA Multiple theratech.com (THTX)|Avalo Therapeutics - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation ELDN|Agenus Inc - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Climb Bio, Inc CLYM|Zura Bio (ZURA) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation ATYR|ADAG (Adagene Inc) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Ikena Oncology, Inc. (IMA)|Enterprise Value to EBITDA Ratio STTK (Shattuck Labs, Inc.)|Total Company Value to Operating Income Before Depreciation Ratio equilliumbio.com|EV/EBITDA Multiple CNTB (Connect Biopharma Holdings Limited)|Business Value to Operating Income Before Depreciation IMUX|ATRA - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to EBITDA InflaRx N.V.|X4 Pharma (XFOR) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to EBITDA Adicet Bio, Inc. (ACET)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Celularity Inc|EV/EBITDA Multiple inmunebio.com|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Barinthus Biotherapeutics plc (BRNS)|KZR: Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple SABS (SAB Biotherapeutics, Inc)|Business Value to Operating Income Before Depreciation AKTX|Enlivex Therapeutics, Ltd. - EV/EBITDA Multiple|QTTB - EV/EBITDA Multiple|GeoVax (GOVX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Edesa Biotech Inc - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization iBio Corp|Enterprise Value to EBITDA Ratio Carisma Tx (CARM)|EV/EBITDA Multiple XTLB|EV/EBITDA Multiple boltbio.com (BOLT)|HCW Biologics - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation APVO|AIM ImmunoTech Inc. - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Aditxt ADTX|GRI Bio, Inc. (GRI) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio xortx.com|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Vyome Holdings|Enterprise Value to EBITDA Ratio Revelation Biosciences Inc (REVB)|Enterprise Value to EBITDA Ratio INDP (Indaptus)|EV/EBITDA Multiple BiondVax Pharmaceuticals (SCNI)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization CalciMedica CALI|AFMD: Enterprise Value to Operating Income Before Depreciation|Allakos Therapeutics - EV/EBITDA Multiple|Company Value to EBITDA IGM Biosciences, Inc.|ITOS: EV/EBITDA Multiple|Ocean Biomedical Corp - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization TC Biopharm|Company Value to EBITDA thirdharmonicbio.com THRD
